Nerve signal recordings during a procedure for trigeminal neuralgia
Measures nerve responses in adults having rhizotomy for trigeminal neuralgia.
Key facts
- Who runs it
- University of Minnesota
- Where
- Minneapolis, United StatesSee the site
- Trial code
- Registry title
- Trigeminal Neuralgia Electrophysiology
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 4 Apr 2022
- Expected to end
- 1 Nov 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Trigeminal Electrophysiology
- Record updated
- 5 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with trigeminal neuralgia (a nerve pain in the face) who are scheduled for a percutaneous rhizotomy. It is also looking for healthy adults as a comparison group.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Patients: facial pain clearly due to trigeminal neuralgia, with a percutaneous rhizotomy (a procedure through the skin on the trigeminal nerve) already scheduled. Healthy volunteers: no facial pain.
Main reasons for not taking part
- Patients: facial pain of unclear origin, not clearly trigeminal neuralgia
- Patients: rhizotomy procedure canceled
- Healthy volunteers: diagnosis or history of facial pain such as TMD or TGN, or history of migraine
- Healthy volunteers: history of fibromyalgia, IBS or CRPS, or chronic pain within the last month
- Healthy volunteers: current acute pain, or not willing to spend two hours in the lab
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Adults of 18 years or older
- Scheduled to undergo percutaneous rhizotomy for facial pain
- Adults of 18 years or older
Who cannot take part
- Diagnosis or history of facial pain such as TMD or TGN
- History of migraine
- History of any functional pain disorder: fibromyalgia, IBS, CRPS
- Facial pain of unclear origin (i.e. not clearly TGN pain)
- Rhizotomy procedure canceled
- Recent chronic pain (within last month)
- Unwilling to participate for two hours in lab
- Current acute pain
Where in United States
- University of MinnesotaMinneapolis, United StatesContact: Matthew MapleTaking people
About the trial
What the trial wants to find out
The study intervention is to perform standard somatosensory evoked responses limited to the face during rhizotomy procedures of the gasserian ganglion (trigeminal ganglion) for the treatment of trigeminal neuralgia. The evoked responses will be measured at two locations before and after the clinical rhizotomy including: the standard contralateral scalp (EEG) and at the gasserian ganglion through an FDA-approved recording electrode.
The 2 groups in the trial
- Trigeminal Electrophysiology
- Controls
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Trigeminal Evoked Responses to Improve Rhizotomy
- Plain-language title
- Nerve signal recordings during a procedure for trigeminal neuralgiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 5 November 2026